Contribute to the Site - CN

Blog
Article

Cancer Network's content includes news, articles from the journal ONCOLOGY, blogs, Image IQs, case studies, videos, and podcasts.

Please send any inquiries or contributions to our managing editor, Ian Ingram: ian.ingram@ubm.com

Blogging

Interested in blogging? We are looking for oncologists interested in contributing regular commentary about life in practice and the ever-changing world of oncology and hematology. Our bloggers generally contribute monthly.

Case Studies

Have a compelling case to share? Submit cases to be posted to our Case Studies section, and we’ll send you $50. Cases must include images with descriptions and a short write-up that includes history, findings, diagnosis, and a discussion.

Image IQ

Have a case that would work great in quiz format? Submit your case to be posted to our Image IQ section, and we’ll send you $75. Image IQs must include an image, clinical history, a question with multiple answer choices, and a discussion of the correct answer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.